Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant in Early Severe COVID-19 Infection
NCT05407597Phase 3Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icatibant in coronavirus disease 2019 (COVID-19), sponsored by Belfast Health and Social Care Trust. Started May 2022; status: completed.
02
Drugs
icatibant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05407597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05407597.